Enfuvirtide [`Fuzeon'] and aripiprazole [`Abilify'] have been added to the Special Pharmaceutical Benefits Program

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 424, 2003 , pp. 11-11(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Aripiprazole, therapeutic use; Enfuvirtide, therapeutic use; Healthcare-news; HIV-infections, treatment; Schizophrenia, treatment

Document Type: Short communication

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$27.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A